Viewing Study NCT04184895


Ignite Creation Date: 2025-12-24 @ 2:14 PM
Ignite Modification Date: 2026-02-02 @ 3:54 PM
Study NCT ID: NCT04184895
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-10-27
First Post: 2019-12-02
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study to Assess the Safety, Tolerability and Immunological Response of ASP2390 in Adult Subjects Allergic to House Dust Mites
Sponsor: Astellas Pharma Global Development, Inc.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Allergic to House Dust Mites View
Keywords:

Keywords

Keyword Brief Keyword Text View
None HDM View
None ASP2390 View
None Safety View
None Tolerability View